• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number ASD44A
Device Problem Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/02/2021
Event Type  Injury  
Manufacturer Narrative
The gore® cardioform asd occluder instructions for use list device embolization as a potential clinical and device adverse event.
 
Event Description
It was reported the physician selected a 44mm gore® cardioform asd occluder to treat an atrial septal defect balloon sized to 22mm with a deficient retro-aortic rim.The device was deployed, locked, and released without issue.During device assessment, the occluder embolized into the right atrium.The physician attempted to recapture the device with a snare; however, the right atrial eyelet was stuck on the tricuspid valve, and the patient was sent to surgery for defect closure and device removal.The patient was doing well following the procedure.
 
Manufacturer Narrative
Echocardiographic and fluoroscopic images were received for evaluation.The images show the retro aortic rim is totally deficient.The posterior rim appears adequate and the superior rim appears to be somewhat deficient.Further images show that following device locking and release, the device appears to not be evenly deployed on the atrial septum.From the echocardiography imaging, a portion of the left disc does appear to be prolapsed through the defect onto the right atrial side at approximately the retro aortic/superior rim location.The lack of tissue capture may have contributed to the embolization of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE CARDIOFORM ASD OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11754071
MDR Text Key250005155
Report Number2017233-2021-01930
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132636518
UDI-Public00733132636518
Combination Product (y/n)N
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 07/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/30/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/07/2022
Device Model NumberASD44A
Device Catalogue NumberASD44A
Was Device Available for Evaluation? No
Date Manufacturer Received04/02/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age31 YR
Patient Weight65
-
-